» Articles » PMID: 22887347

Engineered Variants of InlB with an Additional Leucine-rich Repeat Discriminate Between Physiologically Relevant and Packing Contacts in Crystal Structures of the InlB:MET Complex

Overview
Journal Protein Sci
Specialty Biochemistry
Date 2012 Aug 14
PMID 22887347
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The physiological relevance of contacts in crystal lattices often remains elusive. This was also the case for the complex between the invasion protein internalin B (InlB) from Listeria monocytogenes and its host cell receptor, the human receptor tyrosine kinase (RTK) MET. InlB is a MET agonist and induces bacterial host cell invasion. Activation of RTKs generally involves ligand-induced dimerization of the receptor ectodomain. The two currently available crystal structures of the InlB:MET complex show the same arrangement of InlB and MET in a 1:1 complex, but different dimeric 2:2 assemblies. Only one of these 2:2 assemblies is predicted to be stable by a computational procedure. This assembly is mainly stabilized by a contact between the Cap domain of InlB from one and the Sema domain of MET from another 1:1 complex. Here, we probe the physiological relevance of this interaction. We generated variants of the leucine-rich repeat (LRR) protein InlB by inserting an additional repeat between the first and the second LRR. This should allow formation of the 1:1 complex but disrupt the potential 2:2 complex involving the Cap-Sema contact due to steric distortions. A crystal structure of one of the engineered proteins showed that it folded properly. Binding affinity to MET was comparable to that of wild-type InlB. The InlB variant induced MET phosphorylation and cell scatter like wild-type InlB. These results suggest that the Cap-Sema interaction is not physiologically relevant and support the previously proposed assembly, in which a 2:2 InlB:MET complex is built around a ligand dimer.

Citing Articles

Single-molecule imaging and molecular dynamics simulations reveal early activation of the MET receptor in cells.

Li Y, Arghittu S, Dietz M, Hella G, Hasse D, Ferraris D Nat Commun. 2024; 15(1):9486.

PMID: 39488533 PMC: 11531568. DOI: 10.1038/s41467-024-53772-7.


Crystal structure of an engineered YopM-InlB hybrid protein.

Breitsprecher D, Gherardi E, Bleymuller W, Niemann H BMC Struct Biol. 2014; 14:12.

PMID: 24669959 PMC: 3986869. DOI: 10.1186/1472-6807-14-12.


Hepatocyte growth factor signaling in intrapancreatic ductal cells drives pancreatic morphogenesis.

Anderson R, Delous M, Bosch J, Ye L, Robertson M, Hesselson D PLoS Genet. 2013; 9(7):e1003650.

PMID: 23935514 PMC: 3723531. DOI: 10.1371/journal.pgen.1003650.


Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells.

Dietz M, Hasse D, Ferraris D, Gohler A, Niemann H, Heilemann M BMC Biophys. 2013; 6(1):6.

PMID: 23731667 PMC: 3674922. DOI: 10.1186/2046-1682-6-6.

References
1.
Plotnikov A, Schlessinger J, Hubbard S, Mohammadi M . Structural basis for FGF receptor dimerization and activation. Cell. 1999; 98(5):641-50. DOI: 10.1016/s0092-8674(00)80051-3. View

2.
Courtemanche N, Barrick D . The leucine-rich repeat domain of Internalin B folds along a polarized N-terminal pathway. Structure. 2008; 16(5):705-14. PMC: 2426962. DOI: 10.1016/j.str.2008.02.015. View

3.
Tolbert W, Daugherty J, Gao C, Xie Q, Miranti C, Gherardi E . A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist. Proc Natl Acad Sci U S A. 2007; 104(37):14592-7. PMC: 1965485. DOI: 10.1073/pnas.0704290104. View

4.
Li N, Xiang G, Dokainish H, Ireton K, Elferink L . The Listeria protein internalin B mimics hepatocyte growth factor-induced receptor trafficking. Traffic. 2005; 6(6):459-73. DOI: 10.1111/j.1600-0854.2005.00290.x. View

5.
Ferraris D, Gherardi E, Di Y, Heinz D, Niemann H . Ligand-mediated dimerization of the Met receptor tyrosine kinase by the bacterial invasion protein InlB. J Mol Biol. 2009; 395(3):522-32. DOI: 10.1016/j.jmb.2009.10.074. View